Skip to main content
. 2022 Dec 29;482(1):53–68. doi: 10.1007/s00428-022-03480-8

Table 1.

Diagnostic criteria for accelerated and blast phase chronic myeloid, BCR::ABL1–positive (CML) according to the International Consensus Classification1

Accelerated phase Bone marrow or peripheral blood blasts 10–19% Blast phase Bone marrow or peripheral blood myeloid blasts ≥ 20%
Peripheral blood basophils ≥ 20% Myeloid sarcomab
Presence of additional clonal cytogenetic abnormality in Ph+ cells (ACA)a Bone marrow or peripheral blood lymphoid blasts > 5% is consistent with lymphoblastic crisisc

Ph, Philadelphia chromosome

aSecond Ph, trisomy 8, isochromosome 17q, trisomy 19, complex karyotype ≥ 3 cytogenetic abnormalities, or abnormalities of 3q26.2

bExtramedullary blast proliferation

cImmunophenotypic analysis is required to confirm lymphoid lineage